Related Experiment Videos
Pure red cell aplasia and hepatitis A
J Simmons1, L Stein, A Kaufman
1Department of Family and Community Medicine, University of New Mexico School of Medicine, Albuquerque.
Southern Medical Journal
|November 1, 1993
Summary
A patient with pure red cell aplasia and hepatitis A recovered quickly after starting oral prednisone. This suggests corticosteroids may treat this serious condition by addressing an immune cause.
Area of Science:
- Hematology
- Hepatology
- Immunology
Background:
- Pure red cell aplasia (PRCA) is a rare disorder characterized by the selective absence of erythroid precursors in the bone marrow.
- Hepatitis A is a viral infection that typically causes acute liver inflammation.
- The association between PRCA and viral infections, particularly hepatitis, has been rarely reported, suggesting potential immune-mediated mechanisms.
Observation:
- A patient presented with pure red cell aplasia concurrently with hepatitis A infection.
- The patient's condition was life-threatening, indicating severe anemia and potential complications.
- Initial treatment involved oral prednisone therapy, a type of corticosteroid.
Findings:
- The patient exhibited a dramatic and rapid recovery following the initiation of oral prednisone.
- Erythropoiesis (red blood cell production) was restored, resolving the anemia.
- The swift positive response to corticosteroid treatment was a key observation.
Implications:
- The findings strongly suggest an immune-mediated etiology for pure red cell aplasia in this patient with hepatitis A.
- Corticosteroid therapy appears to be an effective treatment for this specific presentation of PRCA.
- This case highlights the importance of considering immune-related causes in PRCA, especially when associated with viral infections like hepatitis A.